investorscraft@gmail.com

Intrinsic ValueMedical Net, Inc. (3645.T)

Previous Close¥300.00
Intrinsic Value
Upside potential
Previous Close
¥300.00

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2025 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Medical Net, Inc. operates as a specialized digital platform provider in Japan, focusing on medical, dental, and lifestyle information services. The company generates revenue through a combination of advertising, clinic management support, and enterprise marketing services tailored to the healthcare and beauty sectors. Its core offerings include dental implant and orthodontic treatment portals, aesthetic dental resources, and comprehensive medical care directories, positioning it as a niche leader in online healthcare information. Medical Net differentiates itself by aggregating specialized content, such as cosmetic surgery rankings, beauty salon searches, and pet examination resources, catering to both consumers and businesses. The company’s dual revenue model—combining B2C digital advertising with B2B marketing support—allows it to monetize its extensive user base while serving clinics and beauty providers. Despite operating in a competitive digital landscape, Medical Net maintains relevance through localized, high-intent traffic and deep sector expertise, though its market share remains modest compared to broader internet content players.

Revenue Profitability And Efficiency

Medical Net reported revenue of ¥5.25 billion (JPY) for FY 2024, with net income sharply declining to ¥5.96 million, reflecting thin margins in its advertising-driven model. Operating cash flow of ¥119.6 million suggests modest operational efficiency, though capital expenditures were minimal at ¥-32.8 million, indicating limited reinvestment in growth. The company’s profitability challenges stem from high traffic acquisition costs and competitive pressures in digital healthcare advertising.

Earnings Power And Capital Efficiency

Diluted EPS of ¥0.66 underscores weak earnings power, likely due to revenue concentration in low-margin ad services and marketing support. The company’s capital efficiency is constrained by its debt-heavy structure, with total debt of ¥1.03 billion outweighing operating cash flow generation. However, its ¥1.53 billion cash reserve provides liquidity to service obligations.

Balance Sheet And Financial Health

Medical Net’s balance sheet shows liquidity with ¥1.53 billion in cash against ¥1.03 billion in total debt, yielding a net cash position. However, the debt load remains significant relative to its market cap of ¥2.87 billion, suggesting moderate leverage. The absence of aggressive capex signals a focus on maintaining financial stability over expansion.

Growth Trends And Dividend Policy

Growth appears stagnant, with minimal net income and flat operational metrics. The company pays a dividend of ¥3 per share, implying a yield of ~0.1% at current prices, likely aimed at retaining investor interest despite limited growth prospects. Its focus on niche healthcare verticals limits scalability without diversification.

Valuation And Market Expectations

Trading at a market cap of ¥2.87 billion, the company’s valuation reflects its niche position and subdued earnings. A beta of 0.487 indicates lower volatility than the broader market, aligning with its stable but low-growth profile. Investors likely price in limited upside without operational improvements.

Strategic Advantages And Outlook

Medical Net’s deep specialization in Japanese healthcare digital services offers defensibility, but reliance on advertising revenue exposes it to sector cyclicality. Strategic partnerships or vertical integration could enhance margins, though current execution lacks differentiation. The outlook remains neutral, hinging on monetization improvements or market consolidation.

Sources

Company description, financials from disclosed filings (FY 2024), market data from JPX.

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2026202720282029203020312032203320342035203620372038203920402041204220432044204520462047204820492050

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount